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Introduction
Sebopsoriasis is a chronic erythematous scaly dermatitis
that is inconveniencing due to its showing character and
the frequent inefficiency of the various treatments used.
We report through this case the efficiency of low-dose
isotretinoin in this particular form of psoriasis.
Objectives
To emphasize on isotretinoin low-dose efficiency in
sebopsoriasis treatment.
Methods
Miss H.B, 30 years old, with a history of a psoriasis in
the father. The patient was followed up for two years
for a histologically confirmed sebopsoriasis. She received
various therapies, initially put on moisturizers and Imi-
dazoles but with no improvement, then on dermocorti-
coids and vitamin D derivatives. Treatment with UVB
phototherapy could not be achieved, given the profes-
sional constraints of the patient. She was put on Metho-
trexate at 12.5 mg/week dose for six months without
improvement. Treatment based on 5mg Isotretinoin,
three times per week, was recommended allowing the
complete whitening of lesions two months after the
start of treatment with the benefit of one year hindsight.
Results
The sebopsoriasis alters significantly the quality of life of
patients. The treatment is mainly based on local treat-
ments but those are often ineffective. Phototherapy or
other systemic therapies are also used with varying
results. These centro-facial effects during psoriasis
respond well to small doses of isotretinoin at the rate of
5 mg three times per week or every day, which is well
illustrated through this observation.
Conclusion
Our case shows a remarkable efficiency with a good
tolerance of isotretinoin in sebopsoriasis treatment. This
promising result should prompt us to use more this reti-
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